NCT06922318 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT06922318
Title	The COSMYC Trial (COmbined Suppression of MYC)
Acronym	COSMYC
Recruitment	Not yet recruiting
Gender	male
Phase	Phase II
Variant Requirements	No
Sponsors	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Indications	prostate adenocarcinoma
Therapies	Enzalutamide + ZEN-3694 Testosterone cypionate + ZEN-3694
Age Groups:	adult \| senior
Covered Countries	USA

Filter rows:

Showing 1 to 1 of 1 entries

Facility	Status	City	State	Zip	Country	Details
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center		Baltimore	Maryland	21205	United States	Details

Showing 1 to 1 of 1 entries

Filter rows:

*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field

NCT06922318Clinical Trial Detail